Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 01:39PM ET
31.26
Dollar change
+1.54
Percentage change
5.18
%
IndexRUT P/E- EPS (ttm)-1.39 Insider Own10.03% Shs Outstand108.10M Perf Week6.94%
Market Cap3.38B Forward P/E- EPS next Y-1.63 Insider Trans-0.02% Shs Float97.35M Perf Month71.85%
Income-149.78M PEG- EPS next Q-0.36 Inst Own85.92% Short Float5.79% Perf Quarter80.37%
Sales577.74M P/S5.85 EPS this Y32.60% Inst Trans-0.01% Short Ratio4.53 Perf Half Y47.10%
Book/sh3.34 P/B9.37 EPS next Y-24.02% ROA-12.65% Short Interest5.63M Perf Year153.93%
Cash/sh8.91 P/C3.51 EPS next 5Y- ROE-39.70% 52W Range11.66 - 32.60 Perf YTD109.37%
Dividend Est.- P/FCF- EPS past 5Y-22.97% ROI-31.27% 52W High-4.11% Beta0.72
Dividend TTM- Quick Ratio1.44 Sales past 5Y17.16% Gross Margin76.55% 52W Low168.09% ATR (14)2.04
Dividend Ex-Date- Current Ratio1.49 EPS Y/Y TTM25.11% Oper. Margin-26.00% RSI (14)75.03 Volatility8.29% 7.66%
Employees1453 Debt/Eq1.87 Sales Y/Y TTM14.63% Profit Margin-25.93% Recom1.57 Target Price33.00
Option/ShortYes / Yes LT Debt/Eq0.33 EPS Q/Q39.07% Payout- Rel Volume0.67 Prev Close29.72
Sales Surprise7.74% EPS Surprise16.12% Sales Q/Q21.81% EarningsOct 30 BMO Avg Volume1.24M Price31.26
SMA2040.61% SMA5067.03% SMA20076.15% Trades Volume550,423 Change5.18%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Upgrade Evercore ISI In-line → Outperform $18 → $30
Oct-16-24Upgrade H.C. Wainwright Neutral → Buy $24 → $30
Nov-20-23Resumed JP Morgan Neutral $15
Aug-28-23Downgrade H.C. Wainwright Buy → Neutral $85 → $25
Aug-08-23Upgrade Piper Sandler Neutral → Overweight $45
Aug-04-23Initiated SVB Securities Outperform $51
Jul-31-23Upgrade Evercore ISI Underperform → In-line $33
Jun-07-23Upgrade Wedbush Underperform → Neutral $53 → $46
May-16-23Upgrade Wells Fargo Equal Weight → Overweight $70 → $104
Mar-17-23Downgrade JP Morgan Neutral → Underweight $99 → $50
Dec-06-24 08:32AM
Dec-05-24 04:29AM
Dec-03-24 02:51PM
07:17AM
Dec-02-24 04:23PM
01:20PM Loading…
01:20PM
10:12AM
09:54AM
07:02AM
07:00AM
06:08AM
Nov-27-24 07:00AM
Nov-21-24 11:58AM
07:05AM
07:00AM
07:30AM Loading…
Oct-31-24 07:30AM
03:04AM
Oct-30-24 11:00PM
08:15AM
07:10AM
07:02AM
07:00AM
Oct-17-24 10:52AM
08:00AM
Oct-16-24 04:21PM
08:16AM
07:28AM
06:26AM
03:45AM
Oct-15-24 06:09PM
04:43PM Loading…
04:43PM
Oct-01-24 07:00AM
Sep-09-24 07:00AM
Sep-06-24 05:19PM
Sep-03-24 07:00AM
Aug-28-24 07:00AM
Aug-16-24 09:55AM
Aug-14-24 07:00AM
Aug-12-24 03:59PM
Jul-30-24 09:55AM
Jul-25-24 05:30PM
08:10AM
07:11AM
07:00AM
Jul-16-24 08:45AM
Jul-14-24 12:16PM
Jul-01-24 07:00AM
Jun-14-24 10:44AM
Jun-03-24 08:00AM
May-23-24 05:05PM
May-14-24 07:08AM
May-10-24 05:14PM
May-03-24 12:08PM
01:00AM
May-02-24 01:19PM
11:56AM
08:45AM
08:25AM
07:28AM
07:01AM
07:00AM
Apr-25-24 10:01AM
Apr-24-24 10:45AM
Apr-05-24 07:00AM
Apr-04-24 11:33AM
Apr-01-24 12:00PM
07:00AM
Mar-30-24 06:34AM
Mar-28-24 11:50AM
05:01AM
Mar-27-24 04:08PM
09:29AM
09:16AM
07:14AM
07:12AM
07:05AM
07:00AM
Mar-13-24 09:55AM
Mar-11-24 07:00AM
Feb-23-24 11:43AM
Feb-22-24 12:15PM
08:25AM
07:36AM
07:23AM
07:00AM
Jan-19-24 07:46AM
Jan-18-24 02:19PM
07:00AM
Jan-11-24 09:55AM
Jan-09-24 07:00AM
Jan-08-24 07:00AM
Jan-04-24 04:05PM
Dec-27-23 07:00AM
Dec-08-23 04:09AM
Dec-04-23 04:46PM
Nov-28-23 10:51AM
07:30AM
Nov-21-23 07:00AM
Nov-14-23 09:09AM
Nov-10-23 08:00AM
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Paravasthu MukundChief Operating OfficerNov 02 '24Sale16.69447343,459Nov 06 04:27 PM
Puri Michal NathChief Human Resources OfficerOct 31 '24Sale15.7981012,792110,093Nov 04 04:34 PM
Leonard Frank XEVP, Pres., Novocure OncologyNov 01 '24Sale15.945989,531161,236Nov 04 04:34 PM
Paravasthu MukundChief Operating OfficerNov 01 '24Sale15.881602,5403,503Nov 04 04:32 PM
Cordova AshleyChief Financial OfficerAug 02 '24Sale20.1468813,857219,179Aug 05 04:25 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerJun 05 '24Option Exercise22.82124,3732,838,192124,373Jun 07 04:06 PM
VERNON W ANTHONYDirectorJun 04 '24Sale23.8996423,033164,833Jun 06 05:43 PM
Scannell Timothy JDirectorJun 04 '24Sale23.8996423,0272,964Jun 06 05:42 PM
LEUNG GABRIELDirectorJun 04 '24Sale23.8996423,02578,175Jun 06 05:42 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerMar 01 '24Sale16.032,10733,769252,452Mar 05 04:09 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerMar 04 '24Sale16.011,21719,484251,235Mar 05 04:09 PM
Leonard Frank XEVP, Pres., Novocure OncologyMar 01 '24Sale16.031,67926,909160,938Mar 05 04:08 PM
Leonard Frank XEVP, Pres., Novocure OncologyMar 04 '24Sale16.0184013,448160,098Mar 05 04:08 PM
Leonard Frank XEVP, Pres., Novocure OncologyFeb 28 '24Sale16.142,07833,545162,617Feb 29 04:38 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerFeb 28 '24Sale16.142,30337,177254,559Feb 29 04:28 PM